Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
adult patients, 18-70 years of age;
metastatic colorectal cancer scheduled for standard first line chemotherapy;
at least 1 measurable lesion;
ECOG performance score of 0 or 1.
You may not be if
prior chemotherapy for metastatic colorectal cancer;
prior (neo)adjuvant chemotherapy/radiotherapy of a non-metastatic malignancy completed within 6 months prior to study entry;
concomitant malignancies other CRC;
history or evidence of CNS disease unrelated to cancer.
Clareo Health | OPAL Study: A Study of Avastin (Bevacizumab) in Combination With FOLFOXIRI in Patients With Previously Untreated Metastatic Colorectal Cancer
